AstraZeneca
AstraZeneca is seeking a scientific leader to drive potency and functional bioassay development within the Analytical Sciences organization, supporting cell and gene therapy products from early development through commercialization. The role involves setting technical strategy for phase-appropriate methods, building organizational capabilities in cell-line engineering and gene-editing analytics, and partnering across CMC functions to ensure robust product characterization and regulatory compliance. This position may also serve as the Analytical Lead for programs advancing toward late-stage development and launch.
Headquarters
Cambridge, England, United Kingdom
Company Size
10001+ employees
Founded
1999
Digital Biology is part of AstraZeneca, a global biopharmaceutical company focused on discovering, developing, and commercializing prescription medicines. The Digital Biology organization applies data science, computational biology, AI, and software engineering to accelerate drug discovery and translational research across therapeutic areas.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for AstraZeneca.
25% above the average for this role
Senior/Principal Scientist, Analytical Cell Line Engineering and Bioassay Development
Takeda Pharmaceutical Company Limited
Scientist, Analytical Cell Line Engineering & Bioassay Development
BioLife Plasma Services
Senior/Principal Scientist, Cell Based-Potency Assay Development
BioLife Plasma Services
Director, Bioassay Development
Denali Therapeutics
Cell Potency Analytical Development Lead
Artiva Biotherapeutics
Research Associate I/II
Systimmune